These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2643818)

  • 1. Molecular and cellular biology of von Willebrand factor.
    Handin RI; Wagner DD
    Prog Hemost Thromb; 1989; 9():233-59. PubMed ID: 2643818
    [No Abstract]   [Full Text] [Related]  

  • 2. Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor.
    Verheij M; Dewit LG; Boomgaard MN; Brinkman HJ; van Mourik JA
    Radiat Res; 1994 Feb; 137(2):202-7. PubMed ID: 8134544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbation of cultured human vascular endothelial cells by phorbol ester or thrombin alters the cellular von Willebrand factor distribution.
    Reinders JH; Vervoorn RC; Verweij CL; van Mourik JA; de Groot PG
    J Cell Physiol; 1987 Oct; 133(1):79-87. PubMed ID: 3499441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen.
    de Groot PG; Ottenhof-Rovers M; van Mourik JA; Sixma JJ
    J Clin Invest; 1988 Jul; 82(1):65-73. PubMed ID: 2839553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vessel wall-dependent metabolic pathways of the adhesive proteins, von-Willebrand-factor and vitronectin.
    Preissner KT; Pötzsch B
    Histol Histopathol; 1995 Jan; 10(1):239-51. PubMed ID: 7538833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor propeptide in vascular disorders.
    van Mourik JA; Romani de Wit T
    Thromb Haemost; 2001 Jul; 86(1):164-71. PubMed ID: 11487004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation.
    Ruggeri ZM
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):257-79. PubMed ID: 11686099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polydom: a secreted protein with pentraxin, complement control protein, epidermal growth factor and von Willebrand factor A domains.
    Gilgès D; Vinit MA; Callebaut I; Coulombel L; Cacheux V; Romeo PH; Vigon I
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):49-59. PubMed ID: 11062057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cultured endothelial cells regulate platelet adhesion to their extracellular matrix by regulating its von Willebrand factor content.
    Wu YP; Sixma JJ; de Groot PG
    Thromb Haemost; 1995 Apr; 73(4):713-8. PubMed ID: 7495084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor.
    Ruggeri ZM
    J Clin Invest; 1997 Dec; 100(11 Suppl):S41-6. PubMed ID: 9413400
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo and in vitro processing of recombinant pro-von Willebrand factor.
    Turecek PL; Váradi K; Schlokat U; Pichler L; Dorner F; Schwarz HP
    Histochem Cell Biol; 2002 Feb; 117(2):123-9. PubMed ID: 11935288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels.
    Vischer UM; Ingerslev J; Wollheim CB; Mestries JC; Tsakiris DA; Haefeli WE; Kruithof EK
    Thromb Haemost; 1997 Feb; 77(2):387-93. PubMed ID: 9157601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small GTP-binding protein Ral is involved in cAMP-mediated release of von Willebrand factor from endothelial cells.
    Rondaij MG; Sellink E; Gijzen KA; ten Klooster JP; Hordijk PL; van Mourik JA; Voorberg J
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1315-20. PubMed ID: 15130921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of pre-pro-von Willebrand factor and its expression in heterologous cells.
    Bonthron DT; Handin RI; Kaufman RJ; Wasley LC; Orr EC; Mitsock LM; Ewenstein B; Loscalzo J; Ginsburg D; Orkin SH
    Nature; 1986 Nov 20-26; 324(6094):270-3. PubMed ID: 3491324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor gene.
    Randi AM; Sacchi E; Castaman GC; Rodeghiero F; Mannucci PM
    Thromb Haemost; 1993 Feb; 69(2):173-6. PubMed ID: 8456430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.
    Schwachtgen JL; Janel N; Barek L; Duterque-Coquillaud M; Ghysdael J; Meyer D; Kerbiriou-Nabias D
    Oncogene; 1997 Dec; 15(25):3091-102. PubMed ID: 9444957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis of von Willebrand disease.
    Vink T; Sixma JJ
    Curr Stud Hematol Blood Transfus; 1991; (58):78-83. PubMed ID: 1954779
    [No Abstract]   [Full Text] [Related]  

  • 20. The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI.
    Bonnefoy A; Harsfalvi J; Pfliegler G; Fauvel-Lafève F; Legrand C
    Thromb Haemost; 2001 Mar; 85(3):552-9. PubMed ID: 11307830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.